Please wait a minute...
Reviews in Cardiovascular Medicine  2009, Vol. 10 Issue (4): 202-208     DOI: 10.3909/ricm0474
Review Previous articles | Next articles
Dysglycemia/Prediabetes and Cardiovascular Risk Factors
Abdullah Hanna-Moussa*, Michael J. Gardner*, †, L. Romayne Kurukulasuriya*, James R. Sowers*, ‡, §
* Departments of Internal Medicine
Child Health, University of Missouri-Columbia School of Medicine, Columbia, MO
Medical Pharmacology and Physiology, University of Missouri-Columbia School of Medicine, Columbia, MO
§ Harry S. Truman VA Medical Center, Columbia, MO
Download:  PDF(260KB)  ( 169 )
Export:  BibTeX | EndNote (RIS)      
Obesity and diabetes are becoming a pandemic in developing and industrialized countries. Based on the current criteria, 24.1 million Americans have diabetes, and another 57 million have prediabetes. The term prediabetes refers to people who have impaired fasting glucose (100-125 mg/dL), impaired glucose tolerance (2-hour postglucose load of 140-199 mg/dL), or both. Many persons with prediabetes already have microvascular disease consequences (eg, blindness, amputations, kidney failure) similar to those seen in patients with a diagnosis of diabetes. However, it is not established whether prediabetes should be considered a coronary heart disease risk equivalent. Whether dysglycemia is a surrogate for a more complex metabolic condition and/or directly increases cardiovascular disease (CVD) risk remains unclear. However, many studies have shown that hyperglycemia, through various mechanisms, can lead to premature atherosclerosis. In this regard, several diabetes prevention trials have shown that strategies that reduce the rate of conversion to diabetes can also modify CVD risk factors.
Key words:  Prediabetes      Cardiovascular risk      Impaired fasting glucose      Impaired glucose tolerance      Dysglycemia     
Published:  30 December 2009     

Cite this article: 

Abdullah Hanna-Moussa, Michael J. Gardner, L. Romayne Kurukulasuriya, James R. Sowers. Dysglycemia/Prediabetes and Cardiovascular Risk Factors. Reviews in Cardiovascular Medicine, 2009, 10(4): 202-208.

URL:     OR

[1] María M. Adeva-Andany, Carlos Fernández-Fernández, Natalia Carneiro-Freire, Elvira Castro-Quintela, Ana Pedre-Piñeiro, Mónica Seco-Filgueira. Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 41-56.
[2] Michele Provenzano, Giuseppe Coppolino, Teresa Faga, Carlo Garofalo, Raffaele Serra, Michele Andreucci. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 209-220.
[3] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38-46.
[4] Norman E. Lepor, Gerald M. Pohost. Cardiovascular Imaging to Risk-Stratify in Chronic Angina[J]. Reviews in Cardiovascular Medicine, 2009, 10(S1): 30-37.
[5] Matteo Anselmino, Linda Mellbin, Märit Wallander, Lars Rydén. Early Detection and Integrated Management of Dysglycemia in Cardiovascular Disease: A Key Factor for Decreasing the Likelihood of Future Events[J]. Reviews in Cardiovascular Medicine, 2008, 9(1): 29-38.
[6] Zubin Punthakee, Geoff H. Werstuck, Hertzel C. Gerstein. Diabetes and Cardiovascular Disease: Explaining the Relationship[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 145-153.
[7] Thomas D. Giles. A Perspective on Telmisartan and Cardiovascular Risk[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 154-159.
[8] Donna H. Ryan. The Relationship Among Risk Factor Clustering, Abdominal Obesity, and Residual Risk for Cardiovascular Events[J]. Reviews in Cardiovascular Medicine, 2007, 8(1): 9-16.
[9] Lawrence A. Leiter. From Hyperglycemia to the Risk of Cardiovascular Disease[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 3-9.
[10] David R. Holmes, Alice K. Jacobs, Norman E. Lepor, Prediman K. Shah, Alan C. Yeung. Best of TCT 2003[J]. Reviews in Cardiovascular Medicine, 2003, 4(4): 237-249.
No Suggested Reading articles found!